Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Garrido, N.
Right arrow Articles by Pellicer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrido, N.
Right arrow Articles by Pellicer, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update, Vol.6, No.1 pp.67-74, 2000
© European Society of Human Reproduction and Embryology 2000; all rights reserved

Follicular hormonal environment and embryo quality in women with endometriosis

Nicolás Garridocchbdbhc, José Navarrocchbdbhc, José Remohícchbdbhc,cchjaddc, Carlos Simóncchbdbhc,cchjaddc and Antonio Pellicercchbdbhc,cchjaddc,1

cchbdbhc Instituto Valenciano de Infertilidad, and cchjaddc Department of Paediatrics, Obstetrics and Gynaecology, Valencia University School of Medicine, Valencia, Spain

Received on August 18, 1999; accepted on October 26, 1999

Abstract

The use of in-vitro fertilization (IVF) as a therapeutic tool in patients with endometriosis has provided information about the disease and, in particular, aspects of the reproductive process in humans, particularly folliculogenesis, fertilization, embryo development and implantation. Retrospective analyses of IVF and oocyte donation programmes showed impaired implantation in patients with endometriosis. Otherwise, the observation that embryo development was blocked more frequently in cases of endometriosis, suggested that impaired embryo quality may be responsible for the reduced implantation rates. Similarly, women with the disease undergoing oocyte donation had the same chance of implantation as patients without endometriosis, suggesting that the endometrial milieu is not affected in patients with endometriosis. The quality of the oocyte may, therefore, be altered in patients with endometriosis. To investigate this, we studied steroid secretion in women undergoing IVF. Progesterone concentrations in follicular fluid increased with the severity of the disease and an increase in progesterone accumulation in vitro was observed in basal and human chorionic gonadotrophin (HCG)-induced granulosa cell cultures. We postulated that the pattern of progesterone secretion may be related to the release of cytokines by ovarian and/or immune cells. To test this, we measured interleukin (IL)-1, IL-6 and vascular endothelial growth factor (VEGF) concentrations in serum, follicular fluid and granulosa cell cultures. IL-6 concentrations in serum were increased in natural cycles in women with endometriosis and showed a significant decrease in stimulated cycles in IVF. Also, IL-6 concentrations were increased in the follicular fluid of women with endometriosis and released in higher amounts by granulosa–luteal cells from patients with endometriosis. VEGF was accumulated in lower concentrations in the follicular fluid of endometriosis patients. These observations show that the follicular environment is different in cases with endometriosis and suggest that infertility in patients with endometriosis may be related to alterations within the oocyte which, in turn, result in embryos of lower quality, and with a reduced ability to implant.

Key words: cytokines/ / embryo quality/ / endometriosis/ / folliculogenesis/ / infertility


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
H. Nadir Ciray, F. Bener, L. Karagenc, U. Ulug, and M. Bahceci
Impact of assisted hatching on ART outcome in women with endometriosis
Hum. Reprod., September 1, 2005; 20(9): 2546 - 2549.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Salmassi, A.G. Schmutzler, S. Schaefer, K. Koch, J. Hedderich, W. Jonat, and L. Mettler
Is granulocyte colony-stimulating factor level predictive for human IVF outcome?
Hum. Reprod., September 1, 2005; 20(9): 2434 - 2440.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
R. Wu, K. H. Van der Hoek, N. K. Ryan, R. J. Norman, and R. L. Robker
Macrophage contributions to ovarian function
Hum. Reprod. Update, March 1, 2004; 10(2): 119 - 133.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F.-J. Huang, K.-C. Lan, F.-T. Kung, M.-Y. Tsai, C.-Y. Chang, H.-W. Huang, Y.-C. Lin, and S.-Y. Chang
Human cumulus-free oocyte maturational profile and in vitro developmental potential after stimulation with recombinant versus urinary FSH
Hum. Reprod., February 1, 2004; 19(2): 306 - 315.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.S.L. Cunha-Filho, N.A. Lemos, F.M. Freitas, K. Kiefer, M. Faller, and E.P. Passos
Insulin-like growth factor (IGF)-1 and IGF binding protein-1 and -3 in the follicular fluid of infertile patients with endometriosis
Hum. Reprod., February 1, 2003; 18(2): 423 - 428.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.S. Cunha-Filho, J.L. Gross, N.A. Lemos, E.C. Dias, D. Vettori, C.A. Souza, and E.P. Passos
Prolactin and growth hormone secretion after thyrotrophin-releasing hormone infusion and dopaminergic (DA2) blockade in infertile patients with minimal/mild endometriosis
Hum. Reprod., April 1, 2002; 17(4): 960 - 965.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. H. Y. Ng, E. Y. L. Lau, W. S. B. Yeung, and P. C. Ho
HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial
Hum. Reprod., February 1, 2001; 16(2): 319 - 325.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.